Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|19|10|819-829

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.19, Iss.10, 2018-08, pp. : 819-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics in Drug-Metabolizing Enzymes Catalyzing Anticancer Drugs for Personalized Cancer Chemotherapy

By  

Current Drug Metabolism, Vol. 8, Iss. 6, 2007-08 ,pp. : 554-562

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Liver Cirrhosis on the Regulation and Expression of Drug Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 5, Iss. 2, 2004-04 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?

By  

Current Drug Metabolism, Vol. 12, Iss. 1, 2011-01 ,pp. : 24-34

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Metabolizing Enzymes Mechanisms and Functions

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-09 ,pp. : 107-132

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings

By  

Current Medicinal Chemistry, Vol. 21, Iss. 22, 2014-07 ,pp. : 2522-2541

Bentham Science Publishers

Access to resources Recommend Favorite